ZYCORTAL Suspension is given subcutaneously as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease)

Tailor the dose of ZYCORTAL Suspension and the concurrently administered glucocorticoid replacement therapy to the individual dog based on clinical response and normalization of Na + and K concentrations.

Zycortal is an injectable suspsension used as a replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison's disease).

Mar 2, 2025 · INDICATION: For use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease). Prior to each use, thoroughly shake the vial to resuspend the product. ZYCORTAL Suspension replaces the mineralocorticoid hormones only.

For use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison's disease). Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

Zycortal is intended for long term administration at intervals and doses dependent upon individual response. Tailor the dose of Zycortal and the concurrently administered glucocorticoid replacement therapy to the individual dog based on clinical response and normalization of Na⁺ and K⁺ serum concentrations. Initial dose of Zycortal:

Otitis Externa in Dogs. Endocrinology.

ZYCORTAL® Suspension (desoxycorticosterone pivalate injectable suspension) is efficacious, well tolerated and allows tailored dosing for each dog with Addison’s disease.

ZYCORTAL Suspension replaces the mineralocorticoid hormones only. Dogs with combined glucocorticoid and mineralocorticoid deficiency should also be treated with prednisone or prednisolone at an initial dosage of 0.2-0.4 mg/kg/day (0.1-0.2 mg/lb/day).